PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 32 filers reported holding PROQR THRAPEUTICS N V in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $74,000 | -15.9% | 11,100 | -38.7% | 0.00% | -50.0% |
Q2 2016 | $88,000 | 0.0% | 18,100 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $88,000 | -43.9% | 18,100 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $157,000 | -40.5% | 18,100 | 0.0% | 0.00% | -40.0% |
Q3 2015 | $264,000 | -12.6% | 18,100 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $302,000 | -20.7% | 18,100 | +4.0% | 0.01% | -28.6% |
Q1 2015 | $381,000 | +1.1% | 17,400 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $377,000 | +550.0% | 17,400 | +411.8% | 0.01% | +600.0% |
Q3 2014 | $58,000 | – | 3,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,922,570 | $19,053,000 | 7.16% |
DAFNA Capital Management LLC | 1,114,000 | $11,040,000 | 3.79% |
RTW INVESTMENTS, LP | 4,779,135 | $47,361,000 | 1.79% |
Kerrisdale Advisers, LLC | 448,880 | $4,448,000 | 1.57% |
SPHERA FUNDS MANAGEMENT LTD. | 805,000 | $7,978,000 | 0.66% |
Artal Group S.A. | 1,300,000 | $12,883,000 | 0.50% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,571,319 | $45,302,000 | 0.11% |
ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $2,194,000 | 0.09% |
COWEN AND COMPANY, LLC | 103,727 | $1,028,000 | 0.09% |
FRANKLIN STREET ADVISORS INC /NC | 60,000 | $595,000 | 0.07% |